Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study

INTRODUCTION: Although dapoxetine is the only oral pharmacologic agent approved for the treatment of premature ejaculation (PE) and is very effective, the discontinuation rate is high. AIM: To assess the discontinuation rate of patients with PE and the reasons for discontinuation in real-world pract...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyun Jun, Park, Nam Cheol, Kim, Tae Nam, Baek, Seung Ryong, Lee, Kyung Min, Choe, Sangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440632/
https://www.ncbi.nlm.nih.gov/pubmed/28395997
http://dx.doi.org/10.1016/j.esxm.2017.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440632/
https://www.ncbi.nlm.nih.gov/pubmed/28395997
http://dx.doi.org/10.1016/j.esxm.2017.02.003

Ejemplares similares